Abstract
We identified a progenitor cell population highly enriched in samples from invasive and chemo-resistant carcinomas, characterized by a well-defined multigene signature including APOD, DCN, and LUM. This cell population has previously been labeled as consisting of inflammatory cancer-associated fibroblasts (iCAFs). The same signature characterizes naturally occurring fibro-adipogenic progenitors (FAPs) as well as stromal cells abundant in normal adipose tissue. Our analysis of human gene expression databases provides evidence that adipose stromal cells (ASCs) are recruited by tumors and undergo differentiation into CAFs during cancer progression to invasive and chemotherapy-resistant stages.
Avoid common mistakes on your manuscript.
During carcinoma progression, mesenchymal stromal cells become recruited to tumors and contribute to the pool of CAFs. The heterogeneity of CAF populations, changing during disease progression, has been recognized [1]. CAFs can be derived from tissue-resident fibroblasts as well as various other lineages. However, CAF sub-populations are diverse and have incompletely understood effects on disease progression and resistance to therapy. Here, by analyzing public databases of human single-cell RNAseq (scRNA-seq) data, we have identified a CAF progenitor population marked by expression of genes APOD, DCN, LUM, typically accompanied by expression of CFD, CXCL14, PTGDS, MGP, SERPINF1, and DPT. We show that these cells are prominent in the following two settings:
-
1.
Naturally occurring in cancer-free individuals as (a) ASCs previously identified as adipocyte progenitors enriched in the stromal vascular fraction (SVF) of adipose tissue [2], as well as (b) fibro-adipogenic progenitors (FAPs) in skeletal muscle [3]. We refer to the corresponding gene co-expression signature as “the ASC/FAP signature.”
-
2.
Enriched in the tumor microenvironment of invasive and chemoresistant carcinomas of various types.
The ASC/FAP progenitor population has both adipogenic and fibroblastic differentiation potential. In this work, we provide evidence that it is recruited by cancer cells and undergoes differentiation into CAFs (Fig. 1a).
The ASC/FAP signature reflects remarkably similar lists of marker genes in the ASC cluster [2] (Fig. 1b) and the FAP cluster [3] (Fig. 1c). The presence of the same signature in both ASCs and FAPs is also consistent with the finding that adipose tissue is a source of FAP-like cells recruited to skeletal muscle undergoing remodeling [4]. To demonstrate that the ASC/FAP population exists in abundance in each of the 25 adipose tissue samples presented previously [2], we analyzed each of those samples derived from 14 cancer-free individuals. We used an attractor algorithm [5] (Methods in Supplementary Information) designed to converge to a ranked list of genes identifying the core co-expression characterizing cell populations. We independently generated the lists of top-ranked genes for each sample. Supplementary Table 1 shows that all genes mentioned above are consistently top ranked, while Supplementary Fig. 1 demonstrates the abundance of the ASC/FAP population in the SVF.
We identified similarly enriched ASC/FAP genes in cell clusters of bladder [6], ovarian [7], and breast [8] cancer (Fig. 1d). The twelve top differentially expressed genes (DEGs) of a population were also found to have a three-fold enrichment in chemo-resistant samples of pancreatic cancer, referred to as constituting a “chemo-resistance signature” as shown in their extended data Fig. 7b (Fig.1e) [9]. The strong enrichment of the ASC/FAP cell population in multiple cancer types is consistent with the recruitment of this particular progenitor population in aggressive and chemo-resistant cancers. Consistently, lineage tracing and transplantation studies in mouse models indicate that ASCs can be recruited by carcinomas to promote cancer progression [10, 11].
The recruited ASC/FAP cells are typically misrepresented as inflammatory CAFs (“iCAFs”) because they are often included in nonhomogeneous computationally derived clusters that also contain such cells. iCAFs have been defined as fibroblasts expressing IL6 and additional inflammatory mediators [12], and the expression of IL6 has remained a requirement in a Consensus Statement of experts describing iCAFs [13]. IL6 expression can also be induced in a subset of cells in such clusters. However, the ASC/FAP population in its original non-inflammatory status should not be confused with IL6+ iCAFs. For example, the three representative genes for each fibroblastic subpopulation in Fig. 5D of Dominguez et al. [14] are shown in Fig. 1f. Cluster 1 is marked by genes C7, CFD and PTGDS, all three of which are among the twelve in the chemo-resistance ASC/FAP signature in Fig. 1e. Cluster 2 is marked by IL6, HAS1 and CCL2, all among the iCAF signature genes defined previously [15], hence identifying it as the true iCAF population. It was recently suggested that there are “two separate populations of iCAFs: one IL6 positive and another IL6 negative.” [16] In fact, the IL6-negative cluster largely contains the APOD+ ASC/FAP population and should not be characterized as iCAFs.
Single-cell analysis revealed that, in aggressive cancers, cells with the ASC/FAP signature convert to a particular type of CAFs expressing COL11A1, THBS2, and INHBA [17]. This CAF signature was first reported by Kim et al. [18] and included additional genes such as POSTN, COL10A1, and MMP11. One example consistent with the transition is described by Fig. 2a of Wang et al. [19], in which cluster C0 expresses APOD, DCN, and LUM, while cluster C3 adjacent to it expresses COL11A1, THBS2, and INHBA (Fig. 1g). Furthermore, the presence of the COL11A1+ cluster 0, adjacent to C7+CFD+PTGDS+ cluster 1 in Fig. 5D from Dominguez et al., [14] is also consistent with the transition, as is the presence of gene POSTN together with APOD, CFD, and CXCL14 in the same “poor prognosis” cluster (CAF_0) [20] in gastric cancer. COL11A1 is also identified as the collagen marker most strongly associated with poor prognosis [16].
In summary, this commentary draws attention to the APOD+DCN+LUM+ gene signature as representing an important unrecognized population in cancer. These cells are likely derived from ASC/FAPs recruited by carcinomas; however, their origination from other sources cannot be excluded. Their differentiation into COL11A1+ CAFs, accompanying the transition to metastasis, may underlie a mechanism that accounts for the role of adipose tissue in cancer aggressiveness [21]. Genetic manipulations of ASCs in cell culture and animal models of carcinoma progression to chemo-resistance will be necessary to obtain further evidence for the origin of CAFs associated with poor prognosis of cancer. Further research may help in developing appropriate therapeutics targeting the underlying mechanisms.
Data availability
The scRNA-seq data used for the presented results were downloaded from Gene Expression Omnibus (GEO) with accession number GSE129363. The algorithm we developed and used is available at https://github.com/LingyiC/adaptiveAttractor.
References
Caligiuri, G., & Tuveson, D. A. (2023). Activated fibroblasts in cancer: Perspectives and challenges. Cancer Cell, 41, 434–449.
Vijay, J., et al. (2020). Single-cell analysis of human adipose tissue identifies depot- and disease-specific cell types. Nature Metabolism, 2, 97–109.
Rubenstein, A. B., et al. (2020). Single-cell transcriptional profiles in human skeletal muscle. Scientfic Reports, 10, 229.
Sastourné-Arrey, Q., et al. (2023). Adipose tissue is a source of regenerative cells that augment the repair of skeletal muscle after injury. Nature Communications, 14, 80.
Cheng, W.-Y., Yang, O., & T.-H. & Anastassiou, D. (2013). Biomolecular events in cancer revealed by attractor metagenes. PLOS Computational Biology, 9, e1002920.
Chen, Z., et al. (2020). Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma. Nature Communications, 11, 5077.
Hornburg, M., et al. (2021). Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer. Cancer Cell, 39, 928–944.e6.
Wu, S. Z., et al. (2021). A single-cell and spatially resolved atlas of human breast cancers. Nature Genetics, 53, 1334–1347.
Cui Zhou, D., et al. (2022). Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer. Nature Genetics, 54, 1390–1405.
Zhang, Y., et al. (2012). Stromal progenitor cells from endogenous adipose tissue contribute to pericytes and adipocytes that populate the tumor microenvironment. Cancer Research, 72, 5198–5208.
Zhang, T., et al. (2016). CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment. Nature Communications, 7, 11674.
Öhlund, D., et al. (2017). Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. Journal of Experimental Medicine, 214, 579–596.
Sahai, E., et al. (2020). A framework for advancing our understanding of cancer-associated fibroblasts. Nature Reviews Cancer, 20, 174–186.
Dominguez, C. X., et al. (2020). Single-cell rna sequencing reveals stromal evolution into lrrc15+ myofibroblasts as a determinant of patient response to cancer immunotherapy. Cancer Discovery, 10, 232–253.
Elyada, E., et al. (2019). Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. Cancer Discovery, 9, 1102–1123.
Thorlacius-Ussing, J., et al. (2023). The collagen landscape in cancer: profiling collagens in tumors and in circulation reveals novel markers of cancer-associated fibroblast subtypes. The Journal of Pathology, 262(1), 22–36.
Zhu, K., Cai, L., Cui, C., de Los Toyos, J. R., & Anastassiou, D. (2021). Single-cell analysis reveals the pan-cancer invasiveness-associated transition of adipose-derived stromal cells into COL11A1-expressing cancer-associated fibroblasts. PLOS Computational Biology, 17, e1009228.
Kim, H., Watkinson, J., Varadan, V., & Anastassiou, D. (2010). Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1. BMC Medical Genomics, 3, 51.
Wang, Y., et al. (2021). Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response. Cell Discovery, 7, 1–17.
Zhao, Z., et al. (2023). Integrative analysis of cancer-associated fibroblast signature in gastric cancer. Heliyon, 9, e19217.
Lengyel, E., Makowski, L., DiGiovanni, J., & Kolonin, M. G. (2018). Cancer as a matter of fat: the crosstalk between adipose tissue and tumors. Trends Cancer, 4, 374–384.
Funding
This work received no external funding; it was funded by Columbia University’s unrestricted-purpose allocation of inventor’s (D.A.) research of royalties resulting from intellectual property totally unrelated to the work described in this paper.
Author information
Authors and Affiliations
Contributions
D.A., M.K., and L.C. conceived the project and wrote the manuscript. L.C. performed the computational studies. All authors reviewed the manuscript.
Corresponding authors
Ethics declarations
Ethical approval
N/A
Informed consent
N/A
Conflict of interests
The authors have filed a patent application for ideas related to this work. There are no other competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Cai, L., Kolonin, M.G. & Anastassiou, D. The fibro-adipogenic progenitor APOD+DCN+LUM+ cell population in aggressive carcinomas. Cancer Metastasis Rev (2024). https://doi.org/10.1007/s10555-024-10181-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10555-024-10181-y